NCT02301117 2024-09-05A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal ImpairmentTaiho Oncology, Inc.Phase 1 Completed43 enrolled
NCT02837991 2020-06-04A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell CarcinomaCelldex TherapeuticsPhase 1 Terminated16 enrolled
NCT02386111 2018-07-26A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell CarcinomaCelldex TherapeuticsPhase 1 Terminated17 enrolled
NCT02543645 2018-04-30A Study of Varlilumab and Atezolizumab in Patients With Advanced CancerCelldex TherapeuticsPhase 1 Terminated18 enrolled
NCT01331941 2017-11-06A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal FunctionAmgenPhase 1 Completed35 enrolled
NCT00753415 2015-03-17A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)Merck Sharp & Dohme LLCPhase 1 Completed37 enrolled 10 charts
NCT00886353 2009-12-31Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)Apeiron BiologicsPhase 1 Completed22 enrolled